154 related articles for article (PubMed ID: 20013809)
21. SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer.
Balçık-Erçin P; Aysan A; Salık N; Erciyas E
Turk J Gastroenterol; 2023 Aug; 34(8):881-889. PubMed ID: 37427884
[TBL] [Abstract][Full Text] [Related]
22. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis.
Yu Y; Davicioni E; Triche TJ; Merlino G
Cancer Res; 2006 Feb; 66(4):1982-9. PubMed ID: 16488997
[TBL] [Abstract][Full Text] [Related]
23. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
24. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
[TBL] [Abstract][Full Text] [Related]
25. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.
Lei T; Ling X
World J Gastroenterol; 2015 Sep; 21(35):10137-49. PubMed ID: 26401078
[TBL] [Abstract][Full Text] [Related]
26. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
27. Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells.
Xie Y; Yang Y; Ji D; Zhang D; Yao X; Zhang X
Mol Med Rep; 2015 Feb; 11(2):1455-61. PubMed ID: 25370791
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
30. Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion.
Li Z; Tian T; Hu X; Zhang X; Li L; Nan F; Chang Y; Wang X; Sun Z; Lv F; Zhang M
Int J Clin Exp Pathol; 2014; 7(2):631-9. PubMed ID: 24551283
[TBL] [Abstract][Full Text] [Related]
31. APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status.
Scott BJ; Qutob S; Liu QY; Ng CE
Int J Cancer; 2009 Sep; 125(5):1193-204. PubMed ID: 19444912
[TBL] [Abstract][Full Text] [Related]
32. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
33. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
Zanella F; Renner O; García B; Callejas S; Dopazo A; Peregrina S; Carnero A; Link W
Oncogene; 2010 May; 29(20):2973-82. PubMed ID: 20208562
[TBL] [Abstract][Full Text] [Related]
34. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma.
Ng KT; Guo DY; Cheng Q; Geng W; Ling CC; Li CX; Liu XB; Ma YY; Lo CM; Poon RT; Fan ST; Man K
PLoS One; 2012; 7(2):e31655. PubMed ID: 22389672
[TBL] [Abstract][Full Text] [Related]
35. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
36. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
[TBL] [Abstract][Full Text] [Related]
37. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
38. Clusterin plays an important role in hepatocellular carcinoma metastasis.
Lau SH; Sham JS; Xie D; Tzang CH; Tang D; Ma N; Hu L; Wang Y; Wen JM; Xiao G; Zhang WM; Lau GK; Yang M; Guan XY
Oncogene; 2006 Feb; 25(8):1242-50. PubMed ID: 16247463
[TBL] [Abstract][Full Text] [Related]
39. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]